Riccardo Sangermano1, Nathalie M Bax2, Miriam Bauwens3, L Ingeborgh van den Born4, Elfride De Baere3, Alejandro Garanto1, Rob W J Collin1, Angelique S A Goercharn-Ramlal5, Anke H A den Engelsman-van Dijk5, Klaus Rohrschneider6, Carel B Hoyng2, Frans P M Cremers7, Silvia Albert8. 1. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Institute of Molecular Life Sciences, Nijmegen, The Netherlands. 2. Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands. 3. Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium. 4. Rotterdam Eye Hospital, Rotterdam, The Netherlands. 5. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. 6. Universitätsaugenklinik, Ruprecht-Karls-Universität, Heidelberg, Heidelberg, Germany. 7. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Institute of Molecular Life Sciences, Nijmegen, The Netherlands. Electronic address: Frans.Cremers@radboudumc.nl. 8. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Institute of Molecular Life Sciences, Nijmegen, The Netherlands. Electronic address: Silvia.Albert@radboudumc.nl.
Abstract
PURPOSE: To elucidate the functional effect of the ABCA4 variant c.5461-10T→C, one of the most frequent variants associated with Stargardt disease (STGD1). DESIGN: Case series. PARTICIPANTS: Seventeen persons with STGD1 carrying ABCA4 variants and 1 control participant. METHODS: Haplotype analysis of 4 homozygotes and 11 heterozygotes for c.5461-10T→C and sequence analysis of the ABCA4 gene for a homozygous proband. Fibroblasts were reprogrammed from 3 persons with STGD1 into induced pluripotent stem cells, which were differentiated into photoreceptor progenitor cells (PPCs). The effect of the c.5461-10T→C variant on RNA splicing by reverse-transcription polymerase chain reaction was analyzed using PPC mRNA. In vitro assays were performed with minigene constructs containing ABCA4 exon 39. We analyzed the natural history and ophthalmologic characteristics of 4 persons homozygous for c.5461-10T→C. MAIN OUTCOME MEASURES: Haplotype and rare variant data for ABCA4, RNA splice defects, age at diagnosis, visual acuity, fundus appearance, visual field, electroretinography (ERG) results, fluorescein angiography results, and fundus autofluorescence findings. RESULTS: The frequent ABCA4 variant c.5461-10T→C has a subtle effect on splicing based on prediction programs. A founder haplotype containing c.5461-10T→C was found to span approximately 96 kb of ABCA4 and did not contain other rare sequence variants. Patient-derived PPCs showed skipping of exon 39 or exons 39 and 40 in the mRNA. HEK293T cell transduction with minigenes carrying exon 39 showed that the splice defects were the result of the c.5461-10T→C variant. All 4 subjects carrying the c.5461-10T→C variant in a homozygous state showed a young age of STGD1 onset, with low visual acuity at presentation and abnormal cone ERG results. All 4 demonstrated severe cone-rod dystrophy before 20 years of age and were legally blind by 25 years of age. CONCLUSIONS: The ABCA4 variant c.5461-10T→C is located on a founder haplotype lacking other disease-causing rare sequence variants. In vitro studies revealed that it leads to mRNA exon skipping and ABCA4 protein truncation. Given the severe phenotype in persons homozygous for this variant, we conclude that this variant results in the absence of ABCA4 activity.
PURPOSE: To elucidate the functional effect of the ABCA4 variant c.5461-10T→C, one of the most frequent variants associated with Stargardt disease (STGD1). DESIGN: Case series. PARTICIPANTS: Seventeen persons with STGD1 carrying ABCA4 variants and 1 control participant. METHODS: Haplotype analysis of 4 homozygotes and 11 heterozygotes for c.5461-10T→C and sequence analysis of the ABCA4 gene for a homozygous proband. Fibroblasts were reprogrammed from 3 persons with STGD1 into induced pluripotent stem cells, which were differentiated into photoreceptor progenitor cells (PPCs). The effect of the c.5461-10T→C variant on RNA splicing by reverse-transcription polymerase chain reaction was analyzed using PPC mRNA. In vitro assays were performed with minigene constructs containing ABCA4 exon 39. We analyzed the natural history and ophthalmologic characteristics of 4 persons homozygous for c.5461-10T→C. MAIN OUTCOME MEASURES: Haplotype and rare variant data for ABCA4, RNA splice defects, age at diagnosis, visual acuity, fundus appearance, visual field, electroretinography (ERG) results, fluorescein angiography results, and fundus autofluorescence findings. RESULTS: The frequent ABCA4 variant c.5461-10T→C has a subtle effect on splicing based on prediction programs. A founder haplotype containing c.5461-10T→C was found to span approximately 96 kb of ABCA4 and did not contain other rare sequence variants. Patient-derived PPCs showed skipping of exon 39 or exons 39 and 40 in the mRNA. HEK293T cell transduction with minigenes carrying exon 39 showed that the splice defects were the result of the c.5461-10T→C variant. All 4 subjects carrying the c.5461-10T→C variant in a homozygous state showed a young age of STGD1 onset, with low visual acuity at presentation and abnormal cone ERG results. All 4 demonstrated severe cone-rod dystrophy before 20 years of age and were legally blind by 25 years of age. CONCLUSIONS: The ABCA4 variant c.5461-10T→C is located on a founder haplotype lacking other disease-causing rare sequence variants. In vitro studies revealed that it leads to mRNA exon skipping and ABCA4 protein truncation. Given the severe phenotype in persons homozygous for this variant, we conclude that this variant results in the absence of ABCA4 activity.
Authors: Jana Zernant; Winston Lee; Frederick T Collison; Gerald A Fishman; Yuri V Sergeev; Kaspar Schuerch; Janet R Sparrow; Stephen H Tsang; Rando Allikmets Journal: J Med Genet Date: 2017-04-26 Impact factor: 6.318
Authors: Peter Y Zhao; Maria Fernanda Abalem; Daniel Nadelman; Cynthia X Qian; Kari Branham; Dana Schlegel; Naheed Khan; John R Heckenlively; Thiran Jayasundera Journal: Am J Ophthalmol Date: 2017-12-27 Impact factor: 5.258
Authors: Maureen Neitz; Elise D Krekling; Lene A Hagen; Hilde R Pedersen; Jessica Rowlan; Rachel Barborek; Jay Neitz; Adam Crain; Rigmor C Baraas Journal: J Opt Soc Am A Opt Image Sci Vis Date: 2020-04-01 Impact factor: 2.129
Authors: Silvia Albert; Alejandro Garanto; Riccardo Sangermano; Mubeen Khan; Nathalie M Bax; Carel B Hoyng; Jana Zernant; Winston Lee; Rando Allikmets; Rob W J Collin; Frans P M Cremers Journal: Am J Hum Genet Date: 2018-03-08 Impact factor: 11.025
Authors: Jane S Green; Darren D O'Rielly; Justin A Pater; Jim Houston; Hoda Rajabi; Dante Galutira; Tammy Benteau; Amy Sheaves; Nelly Abdelfatah; Donna Bautista; Jim Whelan; Terry-Lynn Young Journal: Eur J Hum Genet Date: 2020-05-28 Impact factor: 4.246
Authors: Keren J Carss; Gavin Arno; Marie Erwood; Jonathan Stephens; Alba Sanchis-Juan; Sarah Hull; Karyn Megy; Detelina Grozeva; Eleanor Dewhurst; Samantha Malka; Vincent Plagnol; Christopher Penkett; Kathleen Stirrups; Roberta Rizzo; Genevieve Wright; Dragana Josifova; Maria Bitner-Glindzicz; Richard H Scott; Emma Clement; Louise Allen; Ruth Armstrong; Angela F Brady; Jenny Carmichael; Manali Chitre; Robert H H Henderson; Jane Hurst; Robert E MacLaren; Elaine Murphy; Joan Paterson; Elisabeth Rosser; Dorothy A Thompson; Emma Wakeling; Willem H Ouwehand; Michel Michaelides; Anthony T Moore; Andrew R Webster; F Lucy Raymond Journal: Am J Hum Genet Date: 2016-12-29 Impact factor: 11.025
Authors: Janine Reurink; Adrian Dockery; Dominika Oziębło; G Jane Farrar; Monika Ołdak; Jacoline B Ten Brink; Arthur A Bergen; Tuula Rinne; Helger G Yntema; Ronald J E Pennings; L Ingeborgh van den Born; Marco Aben; Jaap Oostrik; Hanka Venselaar; Astrid S Plomp; M Imran Khan; Erwin van Wijk; Frans P M Cremers; Susanne Roosing; Hannie Kremer Journal: Int J Mol Sci Date: 2021-06-15 Impact factor: 5.923